Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 and an impressive US$ 3.08 Billion by 2030. The pen needles ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Find Insulin Pen stock video, 4K footage, and other HD footage from iStock. Get higher quality Insulin Pen content, for less—All of our 4K video clips are the same price as HD. Video Back Videos home ...

Find Diabetes Insulin Pen stock video, 4K footage, and other HD footage from iStock. Get higher quality Diabetes Insulin Pen content, for less—All of our 4K video clips are the same price as HD. Video ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...